Skip to main content

Table 4 Effects of SCP on blood lipids in NAFLD mice (n = 10)

From: Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice

Group

TC (mmol/L)

TG (mmol/L)

LDL-C (mmol/L)

HDL-C (mmol/L)

CON

2.89 ± 0.26

0.85 ± 0.11

0.90 ± 0.05

1.58 ± 0.54

CON + SCP

2.85 ± 0.45

0.88 ± 0.25

0.84 ± 0.08

1.53 ± 0.32

NAFLD

5.79 ± 0.70**

1. 47 ± 0.31*

2.15 ± 0.61**

1.06 ± 0.21*

NAFLD + SCP

4.15 ± 0.86#

1.01 ± 0.21#

1.23 ± 0.24#

1.45 ± 0.38#

  1. CON: treated with saline 0.1 mL/10g; NAFLD: treated with saline 0.1 mL/10g; CON + SCP and NAFLD + SCP: treated with SCP (100 mg/kg). Data are expressed as mean ± Standard deviation (n = 10) and analyzed using one-way ANOVA with post hoc test. * P < 0.05, ** P < 0.01 vs. CON and CON + SCP group; # P < 0.05,## P < 0.01 vs. model group
  2. SCP Schisandra polysaccharide, NAFLD non-alcoholic fatty liver disease, TG triglycerides, TC, total cholesterol, LDL-C, low-density lipoprotein cholesterol, SD standard deviation, ANOVA, analysis of variance